Skip to main content

Rob Martienssen and Saraswathy Nochur


Rob Martienssen, a plant genomics researcher at Cold Spring Harbor Laboratory, has been appointed a fellow of the Royal Society of London.

Martienssen is also a co-founder of Orion Genomics. He holds a BA from Cambridge University, and a PhD from the Plant Breeding Institute and Cambridge University.

Alnylam Pharmaceutics said that it has appointed Saraswathy Nochur as vice president of regulatory affairs.

She will be responsible for "leading the global regulatory strategy for the company's development-stage programs and overseeing regulatory operations," the company said.

Most recently, Nochur was vice president of regulatory affairs at The Medicines Company. Before that, she was director of product development and regulatory affairs at CereMedix. She holds a BS and MS in microbiology from the University of Bombay, and a PhD in engineering for the Massachusetts Institute of Technology.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.